Hypermethylation of the gene promoters has been found to be associated with reduced expression of two human β-defensin genes (DEFB1 and DEFB4) in prostate cancer cells (43) and oral carcinoma cells (17), respectively. The gene discussed is DEFB1; the disease is prostate carcinoma.